ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000909.1|Melanin_1 # 1 # 264 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.716	BGC0000909.1|Melanin_1 	1	264	+	Loose	380	24.6386	AcrS	23.81	3000656	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; cephamycin; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAAGTCTCTGAAGGCTGCCGCCGTCGTTGCCGGTTCCATGGTTCTGGCCGGTGCGGTCGCGCCCGCCGCTGCCCACGCCGCCACGGAGGTCCCGCCCGCCAGCCTCACCGGAGCGGTGAACCAGCTCACCAAGGGCCCCGTCAACCTGTCGCCGCTGCACGCGGACAACAAGGGTTCCGCGCTCGGCACGGTCAAGGGGGCGGCGGACTCCCTCACCCAGCAGGGGAACGCCCGGCTGATCGGCGGACTTCCCCTGGGCTGA	MKSLKAAAVVAGSMVLAGAVAPAAAHAATEVPPASLTGAVNQLTKGPVNLSPLHADNKGSALGTVKGAADSLTQQGNARLIGGLPLG	MAKRTKAEALKTRQELIETAIAQFAQHGVSKTTLNDIADAANVTRGAIYWHFENKTQLFNEMWLQQPSLRELIQEHLTAGLEHDPFQQLREKLIVGLQYIAKIPRQQALLKILYHKCEFNDEMLAEGVIREKMGFNPQTLREVLQACQQQGCVANNLDLDVVMIIIDGAFSGIVQNWLMNMAGYDLYKQAPALVDNVLRMFMPDENITKLIHQTNELSVM	39.55	gnl|BL_ORD_ID|601|hsp_num:0	520			6	246	tigecycline; ciprofloxacin; tetracycline; rifampin; chloramphenicol; ampicillin; cefalotin; triclosan
BGC0000909.1|Melanin_2 # 881 # 1447 # 1 # ID=1_2;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.748	BGC0000909.1|Melanin_2 	881	1447	+	Loose	700	24.6386	oleI	41.07	3000866	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	GTGGCCGGGCCTGCGGTCGCCGAGGTCGCGTCCGGGGGAGCGGTGACCGGGGCGGTGAACACAGCGGCCGACTCCGCGAGCCCTGTGGCCGACTCCATGTGTCCGCGGCCCGCCGTCAGCCCCACGGAGGTCACGGGACGGCGGCGGGTGCTGCGGGTGCTGTTCGCGCTGGGGGCCGGAGTGACGCTGGCGCCGGTCTTGGCGGCGTCGGGGTCGGCCGGCCCGGAGGAGGCGCGGTTCGACGAGACGTATCGCGGGCGCCGTATCGTCGGCGACAGGTACGACGCCCAGCGGTCCGGGGACGCCTACTCCGGCGCGTGGCACGTCACCGTGGACGGGCGGCCGCTGCACTTGATGCGCCGGGCCGACGGCAGCTGGATGACCATGGTCGACCACTACCGGTCGTATCCGACAGTGCTCGCCGCCGCGCGCGCGGCCGTCGACGAACTCGGCCCCACCGCACGGCTGGGCGTGCCGCACGGCGGTGGCGGCCACATGGACGACAGCGGTACGCCGGGCGGGCGCAAGGGAGCCGAGAGGGATCATGGCAGTGGTGTACACGCGTAA	MAGPAVAEVASGGAVTGAVNTAADSASPVADSMCPRPAVSPTEVTGRRRVLRVLFALGAGVTLAPVLAASGSAGPEEARFDETYRGRRIVGDRYDAQRSGDAYSGAWHVTVDGRPLHLMRRADGSWMTMVDHYRSYPTVLAAARAAVDELGPTARLGVPHGGGGHMDDSGTPGGRKGAERDHGSGVHA	MTSEHRSASVTPRHISFFNIPGHGHVNPSLGIVQELVARGHRVSYAITDEFAAQVKAAGATPVVYDSILPKESNPEESWPEDQESAMGLFLDEAVRVLPQLEDAYADDRPDLIVYDIASWPAPVLGRKWDIPFVQLSPTFVAYEGFEEDVPAVQDPTADRGEEAAAPAGTGDAEEGAEAEDGLVRFFTRLSAFLEEHGVDTPATEFLIAPNRCIVALPRTFQIKGDTVGDNYTFVGPTYGDRSHQGTWEGPGDGRPVLLIALGSAFTDHLDFYRTCLSAVDGLDWHVVLSVGRFVDPADLGEVPPNVEVHQWVPQLDILTKASAFITHAGMGSTMEALSNAVPMVAVPQIAEQTMNAERIVELGLGRHIPRDQVTAEKLREAVLAVASDPGVAERLAAVRQEIREAGGARAAADILEGILAEAG	44.34	gnl|BL_ORD_ID|1684|hsp_num:0	1824			681	837	oleandomycin
BGC0000909.1|Melanin_4 # 2700 # 4454 # 1 # ID=1_4;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.717	BGC0000909.1|Melanin_4 	2700	4454	+	Loose	1020	32.3426	tlrC	35.79	3002827	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic	antibiotic target protection	Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins	GTGCACCGCTTTTGGCGTCTGGCGCACCGGGTGTTGTGCACTCGTTATGCCTGCGCCCCAGTCGTCCCTTCCGTCCCCTGTGTCCTGTCGGCGCGCAGACATGTCTATATGCTTCAGAAAGCCTCCAAAATTGGGCATTCTTCGCATGTGGTGACCTTGGACGTACGGCCTCAGCTGCTCGACGCACTCTCCGCCCTGCGCGACCGTGTCGCCGCCGCAAGCTTTCCGCTGCCCCTGGCGGGGGCTCCACGCGCGCGTGCCAACCGCGACGAGCTTCTCGCGCAGCTCGACGACTACTTGGTGCCCCGGTTGAGGGACCCCGAAGCGCCGTTGCTGGCCGTCATCGGGGGATCCACCGGGGCCGGCAAGTCGACCCTCGTCAACTCCCTCGTCGGGCGCAGGGTCAGCGAGGCGGGCGTGCTGCGGCCGACCACCCGTACGCCGGTGCTCGTATGCCATCCGGAGGACCATCACTGGTTCAGCGGGATGCGCGTACTGCCCGACCTCACGCGCGTGTGGGTGCCCCATCAGGAACCCGGGGACGATCTGCACGCCCTGGTCGAACGGGGGGAGCGGACGCTGCGTATCGAGACCGCCGAGACGCTGCCGCCCGGGCTCGCCCTCCTCGACGCGCCCGACGTCGACTCCCTCGTCGCCGACAACCGTGTCCTCGCCGCCGAGCTGATCTGCGCCGCGGACATCTGGATCATGGTCACCACGGCCGCCCGCTACGCCGACGCGGTGCCGTGGTATCTGCTGCGTACCGCCAAGGAGAACAAGGCGACCCTGGTCACCGTTCTCGACCGGGTGCCCCATCAGGTGGTGTCCGAGGTCTCGCGGCAGTACGGGGCCCTGCTCGCCAAGGCCGGGCTCGGCGACGTCCCCCGGTTCACCGTGCCCGAGCTGCCCGAGTCCGCGTGGGGCGGGGGGCTTCTTCCGGCCACCGCGGTGGCGACCCTGCGGACCTGGCTCATCCAGCAGGTGCAGGACCCCGCCGCCCGGCAGCAGGCCATGGCCCGTACGGCGTACGGAGTCCTCGACTCGCTCAAGTCGCGCATGCCCGAGCTGGCCGGCGCGGCGGCCGCACAGTACGCCGCCGCGCTGCGCCTCACCGCGGCCGTCGACGGGGCGTACGACAGCGAGTACGCGCGCGTGAAGGGGCGTTTGCAGGCCGGGGCCGTGCTCGCGGGTGACGCGCTGAAGCGATGGCGCGCCTATCCGCTGGACTGCACCGCCGGCGAACTGCTCGACGCGCTCGTCGAAAGCCTCGGCTCGCTCCTGCTGTGCGCCGTCACGGCCGCGGACGAGCGCGTCGACGAGGCCTGGCGGCGCGAGCCCGCCTCGGGTGCCCCGGAGCTGACGGACCGTGATCCCACGCTGGAGAGCGCCGAACACCGGATCGGGATGGCCGCGCGACGCTGGCGGCGCGTCCTCGAGGAGTACGCCGAGGAAGAGGTCCGCAACCTCGACAAGAGCCTCGCGCCGGACGCCGAGGTGGTGGCCGCCCTCGTCGCCACGGCGCTGCTGGGTGGCCGGCGGGCGCGGGCCGCCGGAGAGGGGCTCGCCGAGCGGATCGGCGCGCACGGCGCCCTCAGACTGCGCGACCGGGGCGGACGGCTGCTCTCCGAGTACGTCGACACGACACTGCACATCGAACGCGAGCGCCGTCTCGCCCCCCTCGACGCGCTCGACGTGCACGCCGAGCCACAGGCCGAACTCATCGCCGCGCTGTCCGTACTGCAGAAGGAGAGGTGA	MHRFWRLAHRVLCTRYACAPVVPSVPCVLSARRHVYMLQKASKIGHSSHVVTLDVRPQLLDALSALRDRVAAASFPLPLAGAPRARANRDELLAQLDDYLVPRLRDPEAPLLAVIGGSTGAGKSTLVNSLVGRRVSEAGVLRPTTRTPVLVCHPEDHHWFSGMRVLPDLTRVWVPHQEPGDDLHALVERGERTLRIETAETLPPGLALLDAPDVDSLVADNRVLAAELICAADIWIMVTTAARYADAVPWYLLRTAKENKATLVTVLDRVPHQVVSEVSRQYGALLAKAGLGDVPRFTVPELPESAWGGGLLPATAVATLRTWLIQQVQDPAARQQAMARTAYGVLDSLKSRMPELAGAAAAQYAAALRLTAAVDGAYDSEYARVKGRLQAGAVLAGDALKRWRAYPLDCTAGELLDALVESLGSLLLCAVTAADERVDEAWRREPASGAPELTDRDPTLESAEHRIGMAARRWRRVLEEYAEEEVRNLDKSLAPDAEVVAALVATALLGGRRARAAGEGLAERIGAHGALRLRDRGGRLLSEYVDTTLHIERERRLAPLDALDVHAEPQAELIAALSVLQKER	MRTSPSSQLSLHGVTKRYDDRVVLSQVSLAISPGEKAGIIGDNGAGKSTLLRLLAGEERPDAGEVTVIAPGGVGYLPQTLGLPPRATVQDAIDLAMTELRVLEAELRRTEAALAEAATDEALQDALTAYARLTEQYEVRDGYGADARVDAALHGLGLPGLPRDRRLGTLSGGERSRLALAATLASQPELLLLDEPTNDLDDRAVHWLEEHLSGHRGTVVTVTHDRVFLDRLTATVLEVDGRGVSRHGDGYAGYLAAKAAERRRRQQQYDEWRAELDRNRRLAEANVARLDGIPRKMGKAAFGHGAFRARGRDHGAMSRVRNAKERVERLTANPVAPPADRLSLTARIATADGPGEAPAAELDGVVVGSRLRVPKLRLGAAERLLITGPNGAGKSTLLSVLAGELSPDAGAVSVPGRVGHLRQEETPWPAKLTVLEAFAHNRPGDRDEQADRRLSLGLFEPEALRLRVGELSYGQRRRIELARLVSEPVGLLLLDEPTNHLSPALVEELEEALTGYGGALVLVTHDRRMRSRFTGSHLELREGVVSGAR	106.57	gnl|BL_ORD_ID|1841|hsp_num:0	1997			1074	1332	lincomycin; tylosin; mycinamicin
BGC0000909.1|Melanin_5 # 4451 # 6445 # 1 # ID=1_5;partial=01;start_type=GTG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=3-4bp;gc_cont=0.745	BGC0000909.1|Melanin_5 	4451	6445	+	Loose	1100	30.4166	oleB	37.68	3003036	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic target protection	Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins	GTGACCGCGGTGACTGCCGTCACTGACCACACGGATCACGCCGATCATCCCGAGGACGAGCCCACGGCGGCCGAGCGCATGGGGGGTGACGGCGCGAGGGGCGAGGGCGAAGGCACGGGAGACGTAGCTACGGGAGGCGAAGGTACGCGGGATGAACCCGTGACGGACCGGCCCGGGAAGGACCGATCGGGGAAGGACCGGCCCGGGAAGGATGAGCCGACGGGGGAGGGCTCCGGCGGGGACAACGCCGCCGGTGACGCAGACGGCGGGCACGCACGTGTGGAGCGCGATGCGCTTCACACACGCGTGAAGCGCGGTTTCCCGCCCCCGTCGGCCGCCGACGCCGACGCGTCGGGCCGTACGGAGTCCACGGAACCCGCGGATTCCACGGAGTCCGGCGAGCCCTGGGGCGACGGGCTGATCGCCCGGCGCGTGTCCGAGACGGCCGACGGGCAACAGGAGGTGGCCGCCCTCCTGGAGACCAGGAGCAAGGCCGTCCAGCCGCCCGAGCCCCTCGCGTACGACGGGTCGTTGAGGTCGCGGTTGGACGCCCTGCGCGAGCTGGTGGGGCTGTCGCGGACCCGGCTGGACAGCCGGACGCTCGCAGAGGCAGGCCGGGTACTGGACGAGGCGGTGGCGCGGCGCCGGCTGTCCGGGGAGCACACCGTCGTCGCCATCGCGGGCGCGACCGGCAGCGGCAAGTCCCAGCTCTTCAACGTGCTCGCCGGAGTGACCATTTCGGAAACCGGCGTACGCAGGCCGACCACCGCGGCGCCCATCGCGTGCAGCTGGAGCGACGGCGCGGCCCCGCTCATCGACCGGCTCGGCATCCCCGGACGGCTGCGCAGGCGCCCCCTCCAGAGCCCTGAAGGAGAGGCACAACTGCGCGGGCTCGTCCTGGTGGACCTGCCCGACCACGATTCGGCGGCCGTGCAGCACCGCGAACAGGTCGACCGGATCCTGGCGCTCGTCGACGCGGTCATCTGGGTCGTCGACCCGGAGAAGTACGCGGACGCCGTCCTCCATGAGCGCTATCTGCGGCCCATGGCGGGACACGCCGAGGTCACCTTCGTCGTCCTCAACCAGGTGGACCGGCTGCCCGGCGAGGCCGCACACCAGGTTCTCGACGACCTCAGGAGGCTGCTCGACGAGGACGGGATCGCTCTGGGGGAGTACGGCGAGCCGGGCGCGACCGTGCTCGCGCTGTCCGCCCTCACCGGGGACGGCGTCGGCGAACTGCGCGAGTCGCTCGGGCAGTTCCTGGCCGAGCGCGGGGCCGCCGCGCGCCGCATCTCCGCCGATGTGGAAGCGGCCGGTGCGCGCCTGCGGCCCGTCTATGCGACCGGTCGGCGTACCGGCCTCAGCGAGGAGGCGCGCGACGACTTCGCCGGCCGGCTCGCGGACGCGGTGGGTGCGACCGCTGCGGGCGAGGCCGCCGAGCGCGCGTGGCTGCGCAACGCCAACCGAGCGTGCGGCACGCCCTGGCTGCGGCTGTGGCGGTGGTACCAGGACCGGAGCGAACCCACCACGGGTCGCCTCAGGGTGGGCGCGCCCGCGGACGAGGAGGCGACCGCCCGACAGCGCGTGGAGCAGGCCGTACGTACGGTGGCGGACCGGGCCGCGGTAGGGCTGCCCGCGCCGTGGGCACAGGCGGTGCGCGAGGCGGCCGTACGGGGGTCGCAGGGGCTGCCGGAGGCGCTGGACGAGCTTGTGGTGCGTACGGGGTCGCCGGCGGGGCGGCCGCCGCGGCCGGGCTGGTGGCCGGTCGCCGTGCTCGCTCAGGCGTCGATGACGCTCCTCCAGGTCTTCGGCGGCCTGTGGCTGCTGGGGCAGGTGATCGGGTTCATGTCGCCGAATCTCGGGGTGCCGGTGCTGTTGATGGTCGCGGGCATCGTCGGGGGACCCGTTGTGGAGTGGAGTTGCAGGCTGGCGGCGCGGGGGCCGGCCCGGCGGTACGGACTCGAGGCCGAGCGCCGGCTGAGGGAGGCGGCCGGG	MTAVTAVTDHTDHADHPEDEPTAAERMGGDGARGEGEGTGDVATGGEGTRDEPVTDRPGKDRSGKDRPGKDEPTGEGSGGDNAAGDADGGHARVERDALHTRVKRGFPPPSAADADASGRTESTEPADSTESGEPWGDGLIARRVSETADGQQEVAALLETRSKAVQPPEPLAYDGSLRSRLDALRELVGLSRTRLDSRTLAEAGRVLDEAVARRRLSGEHTVVAIAGATGSGKSQLFNVLAGVTISETGVRRPTTAAPIACSWSDGAAPLIDRLGIPGRLRRRPLQSPEGEAQLRGLVLVDLPDHDSAAVQHREQVDRILALVDAVIWVVDPEKYADAVLHERYLRPMAGHAEVTFVVLNQVDRLPGEAAHQVLDDLRRLLDEDGIALGEYGEPGATVLALSALTGDGVGELRESLGQFLAERGAAARRISADVEAAGARLRPVYATGRRTGLSEEARDDFAGRLADAVGATAAGEAAERAWLRNANRACGTPWLRLWRWYQDRSEPTTGRLRVGAPADEEATARQRVEQAVRTVADRAAVGLPAPWAQAVREAAVRGSQGLPEALDELVVRTGSPAGRPPRPGWWPVAVLAQASMTLLQVFGGLWLLGQVIGFMSPNLGVPVLLMVAGIVGGPVVEWSCRLAARGPARRYGLEAERRLREAAG	MQNAHRSDTGAAALTGTPEKLLPTQPETGSFQVVLDDVVRAPGGRPLLDGVNQSVALGERVGIIGENGSGKSTLLRMLAGVDRPDGGQVLVRAPGGCGYLPQTPDLPPEDTVQDAIDHALAELRSLERGLREAEQALAGAEPEELEGLLGAYGDLLEAFEARDGYAADARVDAAMHGLGLAGITGDRRLGSLSGGEQARLNLACLLAASPQLMLLDEPTNHLDVGALEWLEERLRAHRGSVLVVSHDRVFLERVATALWEVDGERRTVNRHGGGYAGYLQAKAAARRRWEQAYQDWLEDLARQRELARSAADHLATGPRRNTERSNQRHQRNVEKQISARVRNAKERVRRLEENPVPRPPQPMRFRARVEGGGTVGRGGALAELYKVTVGTRLDVPSFTVDPGERILITGHNGAGKSTLLRVLAGDLAPDQGECERPERIGWLPQETEITDRQQSLLAAFAAGLPGIAEEHRGALLGFGLFRPSALGTAVGDLSTGQLRRLALARLLRDPADLLLLDEPTNHLSPALVEDLEEALAHYRGALVVVSHDRMFAQRFTGRRMHMEGGRFVE	116.87	gnl|BL_ORD_ID|1272|hsp_num:0	1388			102	297	oleandomycin
